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Abstract Age-related macular degeneration (AMD) is a
common cause of blindness in the elderly. Caucasian
patients are predominantly affected by the dry form of
AMD, whereas Japanese patients have predominantly the
wet form of AMD and/or polypoidal choroidal vasculop-
athy (PCV). Although genetic association in the 10q26
(ARMS2/HTRA1) region has been established in many
ethnic groups for dry-type AMD, typical wet-type AMD,
and PCV, the contribution of the 1q32 (CFH) region seem
to differ among these groups. Here we show a single
nucleotide polymorphism (SNP) in the ARMS2/HTRA1 locus
is associated in the whole genome for Japanese typical wet-type
AMD (rs10490924: p ¼ 4:1   10 14, OR=4.16) and PCV
(rs10490924: p ¼ 3:7   10 8, OR=2.72) followed by CFH
(rs800292: p ¼ 7:4   10 5, OR=2.08; p ¼ 2:6   10 4,O R=
2.00), which differs from previous studies in Caucasian
populations. Moreover, a SNP (rs2241394) in complement
component C3 gene showed significant association with PCV
(p ¼ 2:5   10 3, OR=3.47). We conclude that dry-type
AMD, typical wet-type AMD, and PCV have both common
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Introduction
Age-related macular degeneration (AMD) is the most com-
mon cause of blindness in elderly people of European descent
and affects more than 1.75 million individuals in the USA
alone [1]. In Japan, the prevalence of AMD has risen from
0.87% in 1988 to 1.3% in 2003 (Japan Ophthalmologists
Association Study Group Report 2006–2008). Steady in-
crease of AMD due to longer life span and improvement of
diagnostic methods has been observed around the country.
The most recent report by Kawasaki et al. describes the
prevalence of early stage AMD in the Funagata study
(Funagata-cho, Yamagata Prefecture, Japan) as 4.4% while
the prevalence of late stage AMD was 1.1%, showing no
difference from a Caucasian study in Australia [2].
AMD is considered a multifactorial disease with in-
volvement of genetic, behavior, and environmental factors,
and primarily affects the macular region of the retina [3].
Clinical phenotypes of AMD are manifold. Small and hard
drusen often appear in normal-aged eyes and do not
necessarily cause AMD [4]. In Caucasians, the early stage
of AMD is associated with an increase in the number of
large soft drusen and progresses to either the dry form or
wet form of the disease [3]. In contrast, Japanese patients
predominantly exhibit wet-type AMD with choroidal neo-
vascularization and few or no drusen [5]. Maruko et al.
have classified wet-type AMD patients into three sub-
groups, namely typical wet-type AMD, polypoidal choroi-
dal vasculopathy (PCV), and retinal angiomatous
proliferation (RAP) [5]. From 289 Japanese patients
examined with wet-type AMD, 35.3%, 54.7%, and 4.5%
were diagnosed with typical AMD, PCV, and RAP,
respectively. In the remaining 5.5% patients, one eye had
PCVand the other eye had typical AMD. Thus, PCV is the
predominant subgroup of wet-type AMD in the Japanese
population. PCV is characterized by branching of the
choroidal vasculature basal to the RPE comprising various
sized polypoidal structures connected to the branching
vascular network, which can be clearly seen by indocyanine
green angiography [6]. PCV can be misdiagnosed as typical
AMD if only fluorescein angiography is performed. The
recent increase in prevalence of PCV is mainly due to the
improvement of diagnostic methods. In most Japanese
patients, typical wet-type AMD and PCVoccur unilaterally
(94.1% and 81.6%, respectively) and show a male
preponderance (71.6% and 77.8%, respectively) [5] consis-
tent with studies of Eastern Asian patients in China and
Korea [7, 8]. However, in Caucasians, PCV predominantly
affectswomenandoccursbilaterallywithaprevalenceranging
from 4% to 14%, which is comparably lower than the Eastern
Asianpopulations[6]. On the other hand, it has been reported
that the incidence of PCV in black individuals exceeds that of
Asians [6]. Although the phenotypic diversity of AMD has
been speculated to be associated with differences in genetic
background, this has not been clearly established.
Initial efforts to investigate the genetic basis of AMD
utilized family studies. A concordance for AMD pheno-
types in twins, and a higher risk of siblings of individuals
with AMD have been reported [9–14]. These early studies
lead to genome-wide linkage analyses using microsatellite
markers to search for chromosomal regions associated with
affected individuals [15–24]. Several candidate regions
including 1q32 and 10q26 were confirmed by a meta-
analysis [25]. Progress in genotyping and sequencing
technology extended detailed genetic association studies
to the entire genome. Age-related eye disease studies
(AREDS) of AMD case-control subjects using 100,000
SNPs resulted in the identification of four chromosomal
regions significantly associated with the disease, namely
CFH (1q32), ARMS2/HTRA1 (10q26), complement com-
ponent 2/complement factor B (C2/BF, 6p21), and comple-
ment component 3 (C3, 19p13) [26], which is consistent
with another genome wide association study recently
reported by Swaroop et al. (IOVS 2009; 50:ARVO E-
Abstract 1614). It should be noted that these genome-wide
scans have been conducted on subjects with both the dry
and wet form of AMD, with the majority of cases
representing the dry form of the disease. However, Zang
et al. have identified 34 SNPs which were associated with
AMD at p value of less than 10
−6 in the AREDS Caucasian
cohort having typical wet-type AMD [27]. They showed
that 1q32 and 10q26 were also significantly associated with
typical wet-type AMD. To date, there are no genome-wide
genetic studies reported for PCV.
Direct examinations of SNPs in chromosomal regions
identified by genome-wide linkage analysis showed that
two genomic loci 1q32 and 10q26 including the CFH,
ARMS2, and HTRA1 genes were associated with AMD in
Caucasians and individuals of Hong Kong [28–32]. The
association between AMD and three SNPs in these gene
regions, namely rs1061170 (CFH), rs10490924 (ARMS2),
and rs11200638 (HTRA1), were verified by a number of
research groups around the world. We also confirmed the
association of rs10490924 and rs11200638 with typical
wet-type AMD in the Japanese cohort [33]. From our
results and others, rs10490924 and rs11200638 have been
shown to strongly associate with dry-type AMD [34],
typical wet-type AMD [31, 32, 34], and PCV [35]. It is still
unclear how these SNPs contribute to the development of
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was confirmed for rs1061170 in Japanese AMD [36–40].
This is probably due to the lower allele frequency of 0.07±
0.02 for this variant in Eastern Asian population compared
to the higher frequency of 0.34±0.03 in Caucasians [41].
However, rs800292, another coding SNP in the CFH gene
region originally associated with AMD in Caucasians [28],
has been shown to associate with typical wet-type AMD
and PCV in Japanese and Chinese populations [39, 42–44].
Thus, there is a clear difference in genetic risk for AMD
based on ethnicity.
Since the association between the CFH gene and AMD
has been established, other components of the complement
pathway have been thoroughly examined in Caucasian
populations. Among them, the 19p13, 6p21 and 4q25 loci,
including the C2, BF, C3, and complement factor I (CFI)
genes, show strong association with AMD [45–49].
However, it still unclear whether CFI or the nearby
PLA2G12A gene is associated with the disease. Lee et al.
analyzed the same AMD associated SNPs in the C2/BF
gene region and reported that there were no differences
between Chinese PCV patients and control groups [43].
Similar results were obtained for PCV in Japanese
population for SNPs in the C2/BF gene region [50].
However, in this study, significant association of disease-
protective haplotype was observed. There is currently no
evidence that the C2/BF gene region is a risk for wet-type
AMD or the C3 gene region a risk for typical wet-type AMD
and PCV for Eastern Asians. With the exception of 1q32,
10q26, 19p13, 6p21, and 4q25 regions, association of other
loci with AMD pathogenesis reported by some genome-wide
genetic studies remains unclear [15–24]. These SNP variants
may be ethnic specific as is the case for CFH.
To investigate the involvement of genetic factors in
Japanese patients who progressed to typical wet-type AMD
and PCV, over 500,568 SNPs covering ARMS2/HTRA1,
CFH, C2/BF, C3,a n dCFI and other regions were
genotyped using Affymetrix Human Mapping 500 K
Arrays and TaqMan assay.
Materials and methods
Subjects
One hundred Japanese patients with typical wet-type AMD
but without PCV (average age 74.56±8.83 years), classified
as 5b by Seddon et al. [51], 100 Japanese patients with
PCV (average age, 72.71±8.25 years), and 190 age-
matched Japanese controls (average age, 72.22±8.51 years)
were recruited for this study (Table 1). All patients were
diagnosed by ophthalmoscopic, fluorescein, and indocya-
nine green angiographic findings. In controls, no signs of
early AMD, such as soft drusen or alterations of the retinal
pigment epithelium in the macula area, were observed
ophthalmoscopically. Informed consent was obtained from
all participants and the procedures used conformed to the
tenets of the Declaration of Helsinki.
Genotyping
DNAwas extracted from blood samples using the Magtration
System 8Lx (Precision System Science Co., Ltd., Tokyo,
Japan), and 50 ng/μl samples were evaluated by gel
electrophoresis.GenotypingwasperformedontheAffymetrix
GeneChip® Human Mapping 500 K Array Set (Affymetrix
Japan, Tokyo, Japan), according to the manufacturer’s
instructions. To check the quality of each array, the SNPs
were initially genotyped by a DM algorithm using
Genotyping Console (Affymetrix). All arrays passed a call
rate of 93% at a confidence threshold of 0.33. For the
association analysis, we genotyped the SNPs by the Bayesian
robust linear model with a Mahalanobis distance classifier
(BRLMM) algorithm using Affymetrix Power Tools
ver.1.10.0 (Affymetrix). Genotyping using Taqman® SNP
GenotypingAssays (Applied Biosystems,Foster City, CA) on
a StepOnePlus™ real-time PCR system (Applied Biosystems)
was performed for the following SNPs in accordance with the
manufacturer’s instructions: rs800292, rs547154, rs2230199,
rs10033900 (Assay ID: C_2530382_10, C_940286_10,
C_26330755_10, C_34681305_10).
Statistical analyses
Statistical analyses were carried out with the R version of
2.7.0 [52]. Deviation of the genotype frequencies in the
controls from those expected under Hardy-Weinberg Equi-
librium (HWE) was assessed by chi-square test. SNPs with
call rate <90% for case and control samples, respectively, a
Hardy–Weinberg p<0.0001 for control samples, a minor
allele frequency <0.05 for all samples, or those that
exhibited poorly defined genotype clusters were disquali-
fied from association analysis. For each case-control study,
Fisher’s exact test was used to compare allelic or genotypic
Table 1 Summary of study populations
AMD PCV Control p value
No. of subjects 100 100 190
Male/female 73:27 81:19 86:104 5.0×10
−10
Mean ± SD 74.56±8.83 72.71±8.25 72.22±8.51 0.08
Range 51–90 52–89 50–89
p values were obtained by Pearson’s chi-square test (5.0×10
−10) and
one-way ANOVA (0.08) among three groups
AMD typical wet-type AMD
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and recessive forms) of each case group with controls. In
the allelic model, the allelic frequencies were compared
between cases and controls using a 2×2 contingency table.
In the genotype model, the frequencies of the three
genotypes were compared using a 2×3 contingency table,
in the dominant model, the frequencies of the homozygote
for the non-risk allele were compared using a 2×2
contingency table, and in the recessive model, the frequen-
cies of the homozygote for the risk allele were compared
using a 2×2 contingency table. Also, association analysis
was performed with the use of the Cochran–Armitage trend
test. After statistical analysis in three different models
(genotype, recessive, and dominant model) and trend test,
the minimum p value of each SNPs were obtained from
lowest p value of these tests. The minimum p values were
used to test whether they were lower than the significance
levels. Odds ratios (ORs) with 95% confidence intervals
(CIs) were estimated for the effects of risk allele and also for
both the dominant and recessive forms of the genotypes. To
account for multiple statistical testing, the false discovery
rate (FDR) was calculated based on the minimum p values
from each typical type of AMD and PCV case-control study
by the method of Benjamini and Hochberg [53], and it was
employed at a significance level of 0.05. Pair wise SNP
linkage disequilibrium (LD) values were calculated from the
genotype data using Haploview ver.4.0.
Logistic regression analysis and calculation of joint OR
Logistic regression analysis was performed to assess the
joint contributions of the three candidate SNPs (rs800292,
rs10490924, and rs2241394) to the risk of typical wet-
type AMD or PCV using R software. To model the
genetic effects, we adopted the following three genetic
models with classification variables: the 2-genotype model
(AA+AB and BB or AA and AB+BB) and the 3-genotype
model (AA, AB, and BB). The logistic regression models
were compared by the Akaike information criterion (AIC)
to obtain the best-fitting model with the lowest AIC.
Univariate logistic regression analysis was initially carried
out for three genotype models on each SNPs, and
multivariate analysis was then performed. The logistic
regression models for all the possible combinations of
SNPs were compared by the AIC to obtain the best-fitting
model with the lowest AIC. Joint ORs for pairs of loci
(rs10490924 and rs800292; rs10490924 and rs2241394;
rs10490924 and rs2241394) were calculated for each
2-locus genotype separately, using the non-risk double
homozygote genotype as a reference. The estimation of
joint ORs was carried out with the R package Epitools.
This analysis added 0.5 to each cell in a case including 0
in contingency table [54].
Results
Genotyping of typical wet-type AMD and PCV
We conducted genotyping on DNA samples obtained from
Japanese patients with typical wet-type AMD and PCV. To
increasethepowerofdetectinggeneticdifference,weselected
samples from AMD cases at stage 5b, at least in one eye
without PCV, for typical wet-type AMD analysis. Stage 5 is
defined as exudative AMD, including nondrusenoid pigment
epithelial detachments, serious or hemorrhage retinal detach-
ments, choroidal neovascular membrane with subretinal or
sub-RPE hemorrhages or fibrosis, or scars consistent with
treatment of AMD. AMD with choroidal neovascular mem-
brane or disciform scar is defined as stage 5b [51]. Although
the controls were age-matched (Table 1), the gender of the
population was biased because of the characteristically
higher incidence of men in Japanese AMD population [6].
One hundred cases versus 190 controls were genotyped for
500,568 tag-SNPs using the Affymetrix Human Mapping
500 K Array Set. For typical AMD, statistical analysis was
performed for a selected 314,950 tag-SNPs through quality
control filters (HWE p<0.0001, minor allele frequency <5%,
and call rate <90%) to reduce low-quality signal. These
SNPs are shown in Fig. 1a and b, and the 77 SNPs
associated with typical wet-type AMD with genotypic
p values<0.0001 are listed in the Supplementary Table S1.
Our study identified several genomic locations as being
potentially associated with AMD risk. Among these SNPs,
rs10490924, rs3750848, and rs2672587 with false discovery
rate <0.05 (Benjamini–Hochberg method) were significantly
associated with typical wet-type AMD in Japanese patients
with a minimum p value of 4.1×10
−14,4 . 6 × 1 0
−14 and
2.2×10
−9, respectively (Table 2). For PCV, statistical
analysis was performed for 313,772 quality controlled
filtered SNPs. These SNPs are shown in Fig. 1c, d, and the
98 SNPs associated with PCV with genotypic p values<
0.0001 are listed in Supplementary Table S2.T w oS N P s :
rs10490924 and rs3750848 are statistically associated with
PCV with a minimum p value of 3.7×10
−8 and 2.4×10
−8,
respectively. These results confirm a strong association of the
AMRS2/HTRA1 gene region with both typical wet-type
AMD and PCV in Japanese, however, we could not
comprehensively evaluate the association between Japanese
AMD and complement related genes probably due to the low
statistical power by this method.
Analysis of the SNPs in ARMS2/HTRA1, CFH, C2/BF, C3,
and CFI gene regions
Despite the success of many genome wide association study
published, not all the genome wide screening data are
analyzed to their full potential. Thus, recently the advantage
j ocul biol dis inform (2009) 2:164–175 167of association analysis on candidate genes selected by
certain criteria has been proposed. We extracted genotyping
data in gene regions, which were associated with typical
wet-type AMD in Caucasian populations, namely ARMS2/
HTRA1, CFH, C2/BF, C3,a n dCFI.U s i n gTaqMan
analysis, we additionally genotyped four SNPs; rs800292
(CFH), rs547154 (C2), rs2230199 (C3), and rs10033900
(CFI), which were significantly associated with Caucasian
typical wet-type AMD but were not covered in the
Affymetrix Human Mapping 500 K Array. rs800292 shows
association with both typical wet-type AMD and PCV
(10
−4<p<10
−3, Table 2) as reported previously [39, 44]. No
difference in genetic frequency between case and control
was detected for rs547154, rs10033900, and rs2230199.
After Benjamini–Hochberg correction, 12 and seven SNPs
showing significant association with typical wet-type AMD
and PCV, respectively (Table 2, Fig. 2), were found at the
threshold FDR <0.05. For typical wet-type AMD, four
SNPs in the CFH gene region including rs800292 appeared
to be significantly associated following the ARMS2/HTRA1
gene region. While in PCV, rs800292 in the CFH gene
region and rs2241394 in the C3 gene region were
significantly associated with the ARMS2/HTRA1 gene
region. These results indicate common and distinctive
aspects of genetic background between typical wet-type
AMD and PCV in Japanese population. We also used
logistic regression to further compare the genetic risk
properties of typical wet-type AMD and PCV. Table 3
summarizes the best-fit and most parsimonious model
analyzed by logistic regression, which was used to explore
the joint contributions of the three candidate SNPs
(rs800292, rs10490924, and rs2241394) to the risk of
typical wet-type AMD and PCV. The AIC for three genetic
models of the candidate SNPs were compared, followed by
logistic regression analysis to assess the joint contributions
of the genetic models with the lowest AIC. These results
suggest that the joint effect of rs800292, rs10490924, and
rs2241394 best described the risk for development of PCV.
However, an effect of rs2241394 was not observed for
typical wet-type AMD. Independent and joint ORs of
typical wet-type AMD combining the genotypes from the
rs800292 and rs10490924 or PCV for the two variants among
rs800292, rs10490924 and rs2241394 were estimated
(Table 4). When three SNPs were combined, some values
Fig. 1 Genome wide screening for Japanese typical wet-type AMD
and PCV. Whole-genome association analyasis of typical wet-type
AMD (a) and PCV (c). The scatter plots were drawn for −log10
(minimum p value) against SNP position in the chromosomes.
Quantile-quantile plot for association results of typical wet-type
AMD (b) and PCV (d). The distribution of observed p values versus
expected p values. Dots represent all the 314950 SNPs and 313772
SNPs analyzed for association studies for typical wet-type AMD and
PCV, respectively
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j ocul biol dis inform (2009) 2:164–175 169appeared to be unreliable because of small numbers of
individuals in some of the genotype combinations. There-
fore, two SNPs were analyzed. The heterozygous (CA) risk
genotype of rs10490924 was detected more often in PCV
cases than in controls with p value of 0.0008 and OR of 2.8
(95% CI=1.5–5.2), however the difference in the frequency
of the heterozygous (CA) at the same loci between typical
wet-type AMD cases and controls did not reach statistical
significance. Both typical wet-type AMD and PCV cases
carried the rs800292 heterozygous (AG) and homozygous
Fig. 2 Schematic view of association and LD results from association
analysis for typical wet-type AMD and PCV in the significantly
associated region. Upper panel, SNPs association results in the
chromosome 1 (a), chromosome 10 (b), and chromosome 19 (c).
This panel shows p values for association testing drawn from the
candidate genes focused study including results using Taqman
genotyping assay. Known genes in the area are shown. Down panel,
LD structure of each region. Pairwise LD was calculated from all the
data set in this study using the methods of Gabriel as implemented in
Haploview. In each box are shown are the LD relationships between
each SNP pair using Haploview’s standard color scheme. Blue circles,
typical wet-type AMD; Red circles, PCV
Table 3 Calculation of AIC by logistic regression analysis in three genotype models
dbSNP ID Model AMD PCV
AIC AIC difference AIC AIC difference
Single
rs800292 Gen 349.6 352.1
Rec 350.4 353.8
Dom 359.6 357
rs10490924 Gen 317.9 347.8
Rec 354.7 354.7
Dom 318.4 357.4
rs2241394 Gen 375.4 366.7
Rec 345.1 373
Dom 374.7 365.3
Joint
rs800292gen + rs10490924gen 291.8 0 325.9 5.5
rs800292gen + rs2241394dom 349.2 57.4 344 23.6
rs10490924gen + rs2241394dom 319.2 27.4 344 23.6
rs800292gen + rs10490924gen + rs2241394dom 293.4 1.6 320.4 0
AMD typical wet-type AMD, Gen genotype model, Rec recessive model, Dom dominant model, AIC Akaike information criterion (the AIC
difference is the difference from the AIC of the best fitting model)
170 j ocul biol dis inform (2009) 2:164–175Table 4 Two-locus odds ratios and p values for different genotypic combinations of the rs800292, rs10490924, and rs2241394 polymorphisms
Genotype combination Number (%)
Control Case Odds ratio (95%CI) p value
AMD Single
rs800292 AA 36 (0.19) 3 (0.03) 1
AG 92 (0.49) 46 (0.48) 6.00 (1.75–20.52) 0.0011
GG 60 (0.32) 47 (0.49) 9.40 (2.73–32.42) 2.3×10
−5
rs10490924 CC 85 (0.45) 18 (0.18) 1
CA 84 (0.44) 30 (0.3) 1.69 (0.87–3.26) 0.1411
AA 20 (0.11) 52 (0.52) 12.28 (5.95–25.33) 2.9×10
−13
Joint
rs10490924 CC rs800292 AA 15 (0.05) 1 (0) 1
AG 38 (0.13) 11 (0.04) 3.09 (0.51–18.69) 0.3234
GG 32 (0.11) 5 (0.02) 1.75 (0.26–11.74) 1
CA AA 15 (0.05) 0 (0) 0.33 (0.01–8.83) 0.4866
AG 45 (0.16) 15 (0.05) 3.52 (0.6–20.71) 0.3353
GG 23 (0.08) 14 (0.05) 6.38 (1.05–38.54) 0.061
AA AA 6 (0.02) 2 (0.01) 3.97 (0.43–36.66) 0.5633
AG 8 (0.03) 20 (0.07) 24.92 (3.89–159.6) 7.1×10
−5
GG 5 (0.02) 28 (0.1) 53.55 (7.94–361.02)
PCV Single
rs800292 GG 36 (0.19) 5 (0.05) 1
GA 92 (0.49) 43 (0.45) 3.37 (1.23–9.18) 0.0156
AA 60 (0.32) 47 (0.49) 5.64 (2.05–15.49)
rs10490924 CC 85 (0.45) 18 (0.18) 1
CA 84 (0.44) 50 (0.5) 2.81 (1.52–5.21) 0.0008
AA 20 (0.11) 32 (0.32) 7.56 (3.55–16.08) 6.0×10
−8
rs2241394 CC + CG 35 (0.19) 6 (0.06) 1
GG 154 (0.81) 93 (0.94) 3.52 (1.43–8.69) 0.0041
Joint
rs10490924 CC rs80092 AA 15 (0.05) 0 (0) 1
AG 38 (0.13) 7 (0.02) 6.04 (0.32–112.28) 0.0994
GG 32 (0.11) 11 (0.04) 10.97 (0.61–198.43) 0.0253
CA AA 15 (0.05) 4 (0.01) 9.00 (0.45–181.74) 0.1131
AG 45 (0.16) 24 (0.09) 16.69 (0.96–291.08) 0.0043
GG 23 (0.08) 21 (0.07) 28.36 (1.6–503.36) 0.0005
AA AA 6 (0.02) 1 (0) 7.15 (0.26–199.68) 0.1014
AG 8 (0.03) 12 (0.04) 45.59 (2.39–869.16) 0.0002
GG 5 (0.05) 15 (0.05) 87.36 (4.44–1,719.03) 4.6×10
−6
rs10490924 CC rs2241394 CC+CG 15 (0.08) 2 (0.02) 1
GG 70 (0.37) 16 (0.16) 1.71 (0.36–8.26) 0.7302
CA CC+CG 17 (0.09) 2 (0.02) 0.88 (0.11–7.06) 1
GG 67 (0.35) 48 (0.48) 5.37 (1.17–24.6) 0.0172
AA CC+CG 3 (0.02) 2 (0.02) 5.00 (0.49–50.83) 0.2098
GG 17 (0.09) 29. (0.29) 12.79 (2.6–62.88) 0.0004
AMD, typical wet-type AMD; 95%CI, 95% confidence intervals; p values were obtained from Fisher’s exact text
j ocul biol dis inform (2009) 2:164–175 171(GG) risk genotype more often than the non-risk genotype
(AA) (typical wet-type AMD cases: p=0.001, OR=6.0; AG
and p=2.2×10
−5, OR=9.4; GG, PCV cases: p=0.016, OR=
3.4; AG and p=0.0002, OR=5.6; GG). A joint OR of 53.5
for typical wet-type AMD in individuals with homozygous
(AA and GG) risk alleles at both loci was observed when
compared with the non-risk genotype (CC and AA), with a
wide range of calculated 95% CI from 7.9 to 361.0.
Similarly, a joint OR of 87.4 for PCV in individuals with
homozygous (AA and GG) risk alleles at the same loci was
observed. A joint analysis of ORs for the rs10490924 and
rs2241394 showed that the risk of PCV was 5.4-fold
(p=0.017) and 12.8-fold (p=0.0004) if individuals had
homozygous (GG) risk genotype of rs2241394 and hetero-
zygous (CA) and homozygous (AA) risk genotype of
rs10490924, respectively, compared with the non-risk geno-
type. A plot of the two-locus genotype specific for typical
wet-type AMD and PCV risks further illustrates the stronger
impact of rs10490924 on these diseases (Fig. 3).
LD block analyses
rs800292 and rs1061170 are located within exon 2 and
exon 9, respectively, of the CFH gene on chromosome 1.
rs800292 was included in LD block 1 indicated in Fig. 2a.
rs1061170 was located in a different LD block from
rs800292 (data not shown). The leading two SNPs
rs10490924 and rs3750848, which have been reported to
associate with AMD [30], maps to a small LD block 1 on
chromosome 10 (Fig. 2b). rs10490924 and rs3750848 were
located within exon 1 and intron 1 of ARMS2. Another
SNP, rs2672587, included in the intronic region of HTRA1
is located downstream of the leading two SNPs between
block 1 and 2 (Fig. 2b). rs2230199 and rs2241394 were
located within exon3 and intron 13 of the C3 gene,
respectively on chromosome 19. rs2241394 was not
included in LD blocks indicated in Fig. 2c.
Discussion
We performed a first genome wide genotyping of Japanese
patients with typical wet-type AMD and PCV using
Affymetrix GeneChip® Human Mapping 500 K Array
and TaqMan assay. Previous genome wide scans on
individuals with the dry and wet-type AMD in Caucasian
populations indicated that CFH and ARMS2/HTRA1 are the
two most significantly associated gene regions for AMD
Fig. 3 Schematic view of two-locus odds ratios. Upper panel,
independently genetic effect of rs10490924 (a) and rs800292 (b). Blue
boxes, typical wet-type AMD; Purple boxes, PCV. Down panel, joint
effect of indicated SNPs to typical wet-type AMD and PCV. Joint odds
ratios for the combination of rs10490924 and rs800292 for typical wet-
type AMD (c), rs10490924 and rs800292 for PCV (d), and rs10490924
and rs2241394 (e) are shown. The combinations had statistically
significant odds ratio are colored. AMD typical wet-type AMD
172 j ocul biol dis inform (2009) 2:164–175followed by C2/BF, C3, and CFI [15–18, 26] (Swaroop A,
et al. IOVS 2009; 50: ARVO E-Abstract 1614). Interest-
ingly, Swaroop et al., reported that the most significantly
associated gene locus was CFH at p values <10
−74
followed by ARMS2 at p values <10
−57. In contrast, the
Japanese typical wet-type AMD patients showed stronger
association with AMRS2/HTRA1 compared to CFH
(Table 2). Affymetrix GeneChip® Human Mapping 500 K
Array used in this study contained 19 SNPs covering the
CFH gene region (13 SNPs passed the quality control
filters). The LD blocks in this region are notably large and
with the additional genotyping of rs800292 by TaqMan
assay, the whole CFH gene region has been covered. Thus,
the association of rs800292 with typical wet-type AMD and
PCV has been confirmed, and the results in this study
clearly indicate a lower contribution of CFH compared to
AMRS2/HTRA1 on typical wet-type AMD and PCV in the
Japanese AMD population. This is consistent with our
earlier findings together with others, which have shown
lower association of CFH compared to ARMS2/HTRA1 for
AMD in Japanese individuals [33, 38–41]. Furthermore,
recent studies demonstrated that 10q26 is more strongly
associated than 1q32 in wet-type AMD in Caucasian
populations [27, 31, 32]. Combining the results of our
study with previous studies suggests that CFH and ARMS2/
HTRA1 independently influence the progression of both
dry-type and wet-type AMD. Taking into consideration, the
lower association of rs1061170 and other variations in CFH
gene reported in Chinese [42, 55, 56]a n dK o r e a n
populations [57], our results may have revealed some of
the common features of AMD patients among East Asian.
However, it should be noted that despite the low frequency
of the risk allele, a significant association between the
rs1061170 variant and typical wet-type AMD have been
demonstrated in some Chinese population [58, 59]. As Chu
et al. have suggested in their paper, the existence of ethnic
group variation within the East Asian population is possible
[59]. We also performed additional genotyping of SNPs in
the C2/BF, C3, and CFI gene regions, with SNPs not
included on the SNP array. rs547154 (C2) is one of the
protective haplotype-tagging SNPs originally reported by
Gold et al. [45] who discovered a risk haplotype and two
protective haplotypes. Kondo et al. have examined the
effects of 11 SNPs in the above gene region in Japanese
PCV cases [50]. Although individual SNPs were not
associated, statistically significant association of a protec-
tive haplotype was found. This protective haplotype was
different from the two haplotypes described by Gold et al. It
is unclear whether this difference is due to the difference in
pathogenesis between dry-type AMD and PCVor ethnicity.
As for rs2230199 (C3), the risk allele frequency was 0 in
subjects analyzed in this study, which was consistent with
the data from the Hap Map project. The risk allele for
rs2230199 was 0.175 in European population (Hap Map
project). In our study, rs2241394 in intron 13 of C3 gene
showed significant association with PCV but not with
typical wet-type AMD (Table 2).
The risk of typical wet-type AMD associated with
rs10490924 was very high (OR=12.3; 95% CI=6.0–25.3),
whereas the risk of PCV conferred by rs10490924 (OR=
7.6; 95% CI=3.5–16.1) was similar to the risk of rs800292
(OR=5.6; 95% CI=2.1–15.5) (Table 4). Tam et al. reported
that combined rs11200638 and rs800292 caused a 23.3-fold
increased risk for exudative AMD [60]. rs11200638 is a
SNP shown to be in LD with rs10490924 [29–31].
Similarly, our results showed that the joint risk of
rs10490924 and rs800292 for PCV was 87.4-fold (Table 4,
Fig. 3).
Structures of CFH and C3 have been reported previously
[61, 62]. CFH consists of twenty short consensus repeats,
each presumed to fold into a distinct structure termed the
complement control protein module (CCP) [61]. Y402H
(rs1061170) and I62V (rs800292) are located in the CCP1
and CCP7, which are implicated in C3/C3b binding and
polyanion binding, respectively [61]. Accordingly,
rs1061170 and rs800292 polymorphisms may differentially
influence the CFH activity. C3 consist of multiple domains
[62]. R80G (rs2230199) is included in the macroglobulin
(MG) 1 domain which is located in the electropositive patch
essential for binding target surfaces such as bacterial cells
or apoptotic host cells [62]. rs2241394, which is located in
intron 13 of the C3 gene, showed strong associated with
PCV in this study (Fig. 2c). Interestingly, exons 13 and 14
adjacent to rs2241394 encode the MG5 domain, which is
also located within the electropositive patch together with
MG1 domain. To investigate the molecular mechanism of
PCV pathogenesis related to rs2241394, further exploration
of SNPs within this region is needed.
The LD block including ARMS2 contains two of the
significantly associated SNPs, rs10490924 and rs3750848
(Fig. 2b, Table 2). Another significantly associated SNP,
rs2672587, was in the intronic region of HTRA1, located
approximately 6 Kbp downstream of ARMS2 (Table 2,
Fig. 2b). The rs11200638 located 512 bp upstream of the
transcription initiation point is absent in the Affymetrix
Human Mapping 500 K Array but has been reported to
associate with AMD at a level comparable to rs10490924
[31, 34, 37]. Our genotyping of rs11200638 by sequencing
also confirmed this result [33]. Our data indicate that both
rs11200638 and rs10490924 share the same LD block
which contains ARMS2 and HTRA1 but different from
rs2672587 (data not shown). This result is consistent with
previous Caucasian studies [29–31]. Some of the candidate
loci appeared in this study may be specific to the Japanese
AMD population or critical for the development of AMD in
combination with ARMS2 (rs10490924) and/or HTRA1
j ocul biol dis inform (2009) 2:164–175 173(rs11200638), and other behavioral, nutritional, and envi-
ronmental factors. Further replication and detailed experi-
ments are needed.
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